U.S. House of Representatives: Committee on Energy and Commerce, Republicans Documents Related to Oversight_and_Investigation

Issues Before the Committee

The House Committee on Energy and Commerce

Documents Related to Oversight and Investigation

Committee Hearing
Issues Relating to the Safety of Accutane
Subcommittee on Oversight and Investigations
December 11, 2002
Committee Hearing
ECNs and Market Structure: Ensuring Best Prices for Consumers.
Subcommittee on Commerce, Trade, and Consumer Protection
October 17, 2002
Committee Hearing
Securing America: The Federal Government's Response to Nuclear Terrorism at Our Nation's Ports and Borders.
Subcommittee on Oversight and Investigations
October 17, 2002
Committee Hearing
An Inquiry into the ImClone Cancer-Drug Story
Subcommittee on Oversight and Investigations
October 10, 2002
Committee Hearing
An Inquiry into the ImClone Cancer-Drug Story
Subcommittee on Oversight and Investigations
October 10, 2002
Committee Hearing
Capacity Swaps by Global Crossing and Qwest: Sham Transactions Designed to Boost Revenues?
Subcommittee on Oversight and Investigations
October 1, 2002
Committee Hearing
Capacity Swaps by Global Crossing and Qwest: Sham Transactions Designed to Boost Revenues?
Subcommittee on Oversight and Investigations
September 24, 2002
Attorney General, U.S. Department of Justice
Request That The Department Of Justice Investigate Whether Ms. Martha Stewart Knowingly Caused Materially False Representations To Be Made To The U.S. House Of Representatives
September 10, 2002
Attorney General, U.S. Department of Justice
Request That The Department Of Justice Investigate Whether Ms. Martha Stewart Knowingly Caused Materially False Representations To Be Made To The U.S. House Of Representatives
September 10, 2002
Attorney General, U.S. Department of Justice
Terrorism-Related Security Measures On Facilities Handling Dangerous Chemicals
August 8, 2002
Administrator, Environmental Protection Agency
Terrorism-Related Security Measures On Facilities Handling Dangerous Chemicals
August 8, 2002
Committee Hearing
Oath Taking, Truth Telling, and Remedies in the Business World.
Subcommittee on Commerce, Trade, and Consumer Protection
July 26, 2002
Deputy Commissioner, Food and Drug Administration
Tauzin, Greenwood Want Details From FDA on Breast Implant Studies
July 11, 2002
Committee Hearing
Creating the Department of Homeland Security: Consideration of the Administration's Proposal
Subcommittee on Oversight and Investigations
July 9, 2002
Chairman and CEO, Xerox Corporation
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman of the Board and Chief Executive Officer, Kmart Corporation
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Acting CEO, Tyco International, Ltd.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
CEO and Chairman of the Board of Directors, Peregrine Systems, Inc.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman and Interim CEO, Adelphia Communications Corporation
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman and CEO, Rite Aid Corporation
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman, Chief Executive Officer and President, Waste Management, Inc.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman & CEO, Qwest Communications International Inc.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
CEO and Chairman of the Board, Microstrategy Incorporated
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman of the Board, Enron Corp.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chief Executive Officer, WorldCom, Inc.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Chairman and Founder, Global Crossing Ltd.
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
CEO and Chairman of the Board, Sunbeam Corporation
Tauzin, Greenwood Want Details On Oversight By Corporate Boards
July 5, 2002
Deputy Commissioner, Food and Drug Administration
Committee Requests Meeting With FDA Regarding Improvements To The Fast-Track Drug Approval Process
June 27, 2002
Committee Hearing
Creating the Department of Homeland Security: Consideration of the Administration's Proposal
Subcommittee on Oversight and Investigations
June 25, 2002
Director, Office of Homeland Security
Ridge on Critical Infrastructure Protection
June 19, 2002
Committee Hearing
An Inquiry into the ImClone Cancer-Drug Story
Subcommittee on Oversight and Investigations
June 13, 2002
Committee Hearing
Oversight and Management of the Government Purchase Card Program: Reviewing Its Weaknesses and Identifying
Subcommittee on Oversight and Investigations
May 1, 2002
Committee Hearing
A Review of the President's Recommendation to Develop a Nuclear Waste Repository at Yucca Mountain, Nevada
Subcommittee on Energy and Air Quality
April 18, 2002
Committee Hearing
A Review of Enhanced Security Requirements at NRC Licensed Facilities.
Subcommittee on Oversight and Investigations
April 11, 2002
President and Chief Executive Officer, ImClone Systems, Inc.
Energy and Commerce Committee Wants ImClone CEO to Detail Stock Trades
March 21, 2002
Deputy Commissioner, Food and Drug Administration
Energy and Commerce Committee Wants ImClone CEO to Detail Stock Trades
March 21, 2002
Comptroller General, U.S. General Accounting Office
Evaluation of Progress In Protecting Federally Owned and Operated Critical Infrastructures and Assets
March 7, 2002
Chairman and Chief Executive Officer, Enron Corporation
Tauzin, Greenwood Want Documents From Enron, Additional Meetings With Senior Company Officials
December 10, 2001
Committee Hearing
A Review of security Issues at Nuclear Power Plants
Subcommittee on Oversight and Investigations
December 5, 2001
Committee Hearing
H.R. 1644, Human Cloning Prohibition Act of 2001, and H.R.____, Cloning Prohibition Act of 2001
Subcommittee on Health
June 20, 2001
Committee Hearing
Continuing Concerns Over Imported Pharmaceuticals
Subcommittee on Oversight and Investigations
June 7, 2001
Committee Hearing
Evaluating the Effectiveness of the Food and Drug Administration Modernization Act.
Subcommittee on Health
May 3, 2001
Secretary, U.S. Department of Health and Human Services
Letter regarding the Interaction of Generic and Pediatric Exclusivity
April 3, 2001
Committee Hearing
Issues Raised by Human Cloning Research
Subcommittee on Oversight and Investigations
March 28, 2001
Committee Hearing
Issues Raised by Human Cloning Research
Subcommittee on Oversight and Investigations
March 28, 2001
Acting Principal Deputy Commissioner, Food and Drug Administration
Implementation Of Policies Concerning Personal Importation Of Prescription Drugs At The Mexico-U.S. Border
March 14, 2001
Acting Principal Deputy Commissioner, Food and Drug Administration
Increase of Pharmaceutical Products Being Shipped Into The U.S. From Foreign Sources
March 9, 2001
Acting Principal Deputy Commissioner, Food and Drug Administration
Adequacy Of Federal Oversight Of Clinical Research Using Cloning Technology
March 8, 2001
Acting Principal Deputy Commissioner, Food and Drug Administration
Adequacy Of Federal Oversight Of Clinical Research Using Cloning Technology
March 8, 2001
Assistant to the President for National Security Affairs, National Security Council
The Proposed Acquisition Of The Silicon Valley Group, Inc. (SVG) Of San Jose, California, By ASM Lithography Holding N.V. (ASML) Of The Netherlands
March 1, 2001
Secretary, Department of the Treasury
The Proposed Acquisition Of The Silicon Valley Group, Inc. (SVG) Of San Jose, California, By ASM Lithography Holding N.V. (ASML) Of The Netherlands
March 1, 2001

Comment On This Page